Business
NuLife Announces Pre-Clinical Trial of NuLife Technique
NuLife Announces Pre-Clinical Trial of NuLife Technique.
About this update from Gulf West Security Network Inc.
[{"type":"text","content":"\nNuLife Announces Pre-Clinical Trial of NuLife Technique\n\nNuLife Announces Pre-Clinical Trial of NuLife Technique\n\nNEWPORT BEACH, CA--(Marketwired - August 15, 2017) - NuLife Sciences (OTCQB: NULF) through the company's wholly-owned subsidiary, NuLife BioMed, Inc., today announced that it is initiating a pre-clinical trial on the NuLife Technique, a means to potentially eliminate the need for organ or tissue matching between donor and recipient in organ transplants and the necessity for anti-rejection drugs after surgery.The trial, commenced on August 8th at Florida International University, and will evaluate the NuLife process in an autologous setting, meaning an organ is removed from and transplanted back to the same donor. The objective of the study is to prove that the NuLife Technique is viable.This first of a series of pre-clinical trials, a kidney will be removed from a pig, the NuLife Technique will be applied to the kidney, and it will be transplanted back into the original \"donor\" pig. Two weeks after the transplant, both kidneys (the control kidney left in the animal and the kidney that had the NuLife Process applied) will be histologically compared. Results from the trial will be published as a series, with findings presented as each step of the pre-clinical work is completed.The surgeries are being conducted at the Florida International University (FIU) under the sponsorship of the FIU Chair of Surgery, Jaime Rodriguez, MD, Associate Professor of Surgery. Our two lead investigators and transplant surgeons, Dr. Arenas and Dr. Hranjec performed the first set of experiments. Juan Arenas, MD, FACS, MBA, is a board-certified transplant surgeon, Director of the Solid Organ Transplant Institute, and the Chair of Solid Organ Transplant at Memorial Regional Hospital in Hollywood, Florida. Prior to this role, he served as the Chief of the Division of Surgical Transplantation at the University of Texas (UT) Southwestern Medical Center for the past 10 years. Tjasa Hranjec, MD, MS-CR is a Board certified trauma/critical care and transplant surgeon, the director of the Transplant Intensive Care Unit at the Memorial Regional Hospital in Hollywood. The NuLife process is being conducted in the science laboratory at Nova Southeastern University. \"After 15 years of committed research conducted on this technology, we're thrille...